WINTON GROUP Ltd - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$366,091
+126.4%
33,433
+173.8%
0.03%
+114.3%
Q2 2023$161,687
-35.5%
12,212
-33.7%
0.01%
-6.7%
Q1 2023$250,832
-34.2%
18,430
-5.6%
0.02%
-40.0%
Q4 2022$381,362
-59.1%
19,527
-60.1%
0.02%
-59.0%
Q3 2022$932,000
-13.5%
48,903
-6.4%
0.06%
+7.0%
Q2 2022$1,077,000
+194.3%
52,264
+359.2%
0.06%
+200.0%
Q1 2022$366,00011,3810.02%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders